SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-06-007598
Filing Date
2006-05-16
Accepted
2006-05-16 16:54:31
Documents
1
Period of Report
2006-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 7396
  Complete submission text file 0001140361-06-007598.txt   9373
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1691 MICHIGAN AVE SUITE 435 MIAMI FL 33139
Business Address 305-534-3383
Clavijo James (Reporting) CIK: 0001306908 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 06846618